T M Wong Selected Research

kappa Opioid Receptors (kappa Opioid Receptor)

2/2007	Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels.
11/2002	Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia.
11/2001	Protein kinase C-epsilon is a trigger of delayed cardioprotection against myocardial ischemia of kappa-opioid receptor stimulation in rat ventricular myocytes.
10/2001	Signaling pathway mediated by kappa-opioid receptor is impaired in cardiac hypertrophy.
7/2001	Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes.
12/2000	kappa-Opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell line.
8/2000	kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T M Wong Research Topics

Disease

8	Infarction (Infarctions) 07/2009 - 12/2000
5	Ischemia 02/2010 - 05/2000
5	Cardiac Arrhythmias (Arrythmia) 01/2004 - 08/2000
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2001 - 12/2000
2	Right Ventricular Hypertrophy 01/2004 - 10/2001
2	Neoplasms (Cancer) 12/2000 - 02/2000
2	Carcinoma (Carcinomatosis) 02/2000 - 02/2000
1	Knee Injuries (Knee Injury) 08/2012
1	Pain (Aches) 08/2012
1	Osteoarthritis 08/2012
1	Heart Diseases (Heart Disease) 02/2008
1	Coronary Occlusion 02/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2004
1	Hypoxia (Hypoxemia) 11/2002
1	Cardiomegaly (Heart Hypertrophy) 10/2001
1	Hypertension (High Blood Pressure) 12/2000
1	Squamous Cell Carcinoma of Head and Neck 02/2000
1	Thrombosis (Thrombus) 02/2000
1	Hemorrhagic Cystitis 02/2000
1	Acute Kidney Injury (Acute Renal Failure) 02/2000
1	Hydronephrosis 02/2000
1	Hypocalcemia 02/2000
1	Pyelitis 02/2000
1	Cystitis 02/2000
1	Hypokalemia 02/2000

Drug/Important Bio-Agent (IBA)

7	kappa Opioid Receptors (kappa Opioid Receptor)IBA 02/2007 - 08/2000
4	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA 02/2004 - 08/2000
3	CalciumIBA 02/2010 - 10/2001
3	Verapamil (Calan)FDA LinkGeneric 01/2004 - 12/2000
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2009 - 02/2008
2	calphostin CIBA 01/2001 - 08/2000
2	Protein Kinase CIBA 01/2001 - 08/2000
2	Proteins (Proteins, Gene)FDA Link 12/2000 - 02/2000
1	ViscosealIBA 08/2012
1	Analgesics (Analgesic Drugs)IBA 08/2012
1	Hyaluronic Acid (Hyaluronan)IBA 08/2012
1	LipopolysaccharidesIBA 02/2010
1	benoxathianIBA 02/2008
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2008
1	CGP 20712AIBA 02/2008
1	Prazosin (Minipress)FDA LinkGeneric 02/2008
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2008
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2008
1	Testosterone (Sustanon)FDA Link 02/2008
1	Morphine (MS Contin)FDA LinkGeneric 11/2004
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 02/2004
1	tetrandrineIBA 01/2004
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2004
1	SaltsIBA 01/2004
1	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2004
1	Protein Kinase C-epsilonIBA 11/2001
1	Opioid Analgesics (Opioids)IBA 07/2001
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2001
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2001
1	Adenosine Triphosphate (ATP)IBA 01/2001
1	5-hydroxydecanoic acidIBA 01/2001
1	naltrindoleIBA 01/2001
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2001
1	chelerythrineIBA 01/2001
1	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 01/2001
1	norbinaltorphimineIBA 01/2001
1	Type C PhospholipasesIBA 12/2000
1	SolutionsIBA 12/2000
1	SodiumIBA 08/2000
1	IonophoresIBA 08/2000
1	Monensin (Coban)IBA 08/2000
1	Amiloride (Midamor)FDA LinkGeneric 08/2000
1	bisindolylmaleimide IIBA 08/2000
1	Dihydrotachysterol (AT 10)IBA 05/2000
1	RNA Precursors (Precursor, mRNA)IBA 02/2000
1	EnzymesIBA 02/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2000
1	DiureticsIBA 02/2000
1	ElectrolytesIBA 02/2000

Therapy/Procedure

1	Activities of Daily Living (ADL) 08/2012
1	Ligation 02/2010
1	Ovariectomy (Oophorectomy) 07/2009
1	Stents 02/2000
1	Combination Drug Therapy (Combination Chemotherapy) 02/2000
1	Therapeutics 02/2000